On the use and abuse of X in the TNM classification
β Scribed by Frederick L. Greene; James Brierley; Brian O'Sullivan; Leslie H. Sobin; Christian Wittekind
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 48 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
One frequent area of uncertainty in assigning proper staging categories is the use of the βXβ suffix when assigned to the tumor (T), lymph node (N), or metastasis (M) categories of the TNM classification system. When X is used, patients ordinarily cannot be assigned a stage, e.g., Stage III. The objective of this communication was to clarify the use of X.
π SIMILAR VOLUMES
## Abstract A prospective 5βyear clinical trial was conducted by the National Cancer Institute of Canada to assess the TNM classification for breast cancer proposed by the International Union Against Cancer (UICC). The study period was 1960β1964 with a 5βyear followβup on all cases. Excluding those
## Abstract The TNM classification is a worldwide benchmark for reporting the extent of malignant disease and is a major prognostic factor in predicting the outcome of patients with cancer. The objectives for cancer staging were defined by the International Union Against Cancer (UICC) TNM Committee
## Abstract Staging systems for cancer, including the most universally used TNM classification system, have been based almost exclusively on anatomic information. However, the question arises whether staging systems should be based on this information alone. Other parameters have been identified th